Sequence analysis of the murine gamma-herpesvirus 68 (gHV68) genome previously identified several open reading frames (ORFs) located at the left end of the viral genome that do not share homology with other known herpesvirus or cellular genes. Here, we show that one of these ORFs, M4, encodes a secreted glycoprotein that influences the establishment of splenic latency at early times post-infection. We generated a mutant virus containing a premature translation termination codon in the M4 ORF (M4.STOP), and demonstrated that this mutant virus replicates in vitro equivalent to wild type and marker rescue (M4.MR) viruses. M4.STOP was also capable of high-titer lytic replication in vivo, but at 16 days postinfection the establishment of latency in the spleen was significantly impaired. The defect in the establishment of splenic latency was apparent following either intranasal or intraperitoneal inoculation. In contrast, the M4.STOP mutant did not exhibit a defect in the establishment of latency in peritoneal cells. These results suggest that M4 mediates an extracellular host-pathogen interaction that impacts the establishment of latent infection in the spleen, but not the peritoneum. D
Introduction
The g-herpesviruses include the human pathogens Epstein -Barr Virus (EBV) and Kaposi's sarcoma-associated herpesvirus . These viruses establish life-long infection of the host and are associated with a number of malignancies. Murine g-herpesvirus 68 (gHV68) is a member of the g 2herpesvirus subfamily based on genome sequence (McGeoch et al., 2005; Virgin et al., 1997) . gHV68 has proven to be a useful model for studying the in vivo pathogenesis of g-herpesvirus infection as it is capable of infecting both inbred and outbred strains of mice (Sunil-Chandra et al., 1992a , 1992b , and it is amenable to genetic manipulation after being cloned as a bacterial artificial chromosome (BAC) (Adler et al., 2000) . The pathogenesis of gHV68 has been previously reviewed (Nash and Sunil-Chandra, 1994; Simas and Efstathiou, 1998; Speck and Virgin, 1999; . Briefly, infection results in an acute, productive infection of multiple organs and a CD4 + T-cell dependent splenomegaly (Usherwood et al., 1996a) . Acute virus replication is largely cleared by 2 to 3 weeks post-infection (Tibbetts et al., 2003) . Subsequently, gHV68 is present in its persistent, latent form, during which time the genome is maintained in infected cells in the absence of detectable preformed infectious virus. gHV68 establishes a latent infection in B cells, macrophages, dendritic cells, and persists in lung epithelial cells (Flano et al., 2000 Stewart et al., 1998; Sunil-Chandra et al., 1992a , 1992b Weck et al., 1999a Weck et al., , 1999b . Similar to EBV infection, memory B cells appear to maintain gHV68 latency long-term (Flano et al., 2002; Willer and Speck, 2003) .
Sequence analysis of the gHV68 genome identified 80 ATG initiated open reading frames (ORFs) predicted to encode proteins of at least 100 amino acids in length (Virgin et al., 1997) . While the majority of these ORFs were homologous to known genes present in other g-herpesviruses, a number were found which have no known cellular or viral homologues.
Eleven of these ORFs were designated with the ''M'' nomenclature, and M1 through M4 comprise a unique gene cluster adjacent to the terminal repeat at the far left end of the genome. The position of this locus is analogous to the transterminal repeat region found among several g-herpesviruses in which each virus encodes unique genes thought to impact host pathogenesis (Virgin et al., 1997) . Confirmation of this notion for gHV68 came with the independent isolation of two deletion mutants that lack this region. These two viruses, characterized as gHV68 D9473 (Clambey et al., 2002) and MHV-76 (Macrae et al., 2001) , contain nearly identical genomic structure in which the first 9.5 kilobases (kb) of coding sequence adjacent to the terminal repeat is lost, effectively deleting the M1, M2, M3, and M4 genes along with eight viral tRNA-like genes. Study of the D9473 mutant demonstrated profound differences in pathogenesis, including attenuated acute infection and altered establishment of and reactivation from latency (Clambey et al., 2002) . Systematic genetic mapping in this region became a goal for understanding the molecular pathogenesis of gHV68 infection. Several of the phenotypic features of D9473 could be attributed to the loss of specific gene function within the 9.5-kb deletion. For example, disruption of the M1 ORF results in an increased efficiency of reactivation from peritoneal latency (Clambey et al., 2000) , while the M2 ORF was found to be critical for the establishment of splenic latency following intranasal infection (Jacoby et al., 2002) . In contrast, specific disruption of the M3 ORF did not impact viral latency although it altered the course of intracranial infection . Certain features of the D9473 virus could not be explained by these targeted studies, however, including differences in acute infection and the persistent defect in splenic latency at late times post-infection (Clambey et al., 2002) . These differences may result from the combinatorial effects of multiple gene deletions in the region, or be the result of genes that have not yet been studied in isolation, including M4. We set about producing a targeted disruption of the M4 ORF in order to further fine map the genetic determinants of this locus and determine the role of M4 in the absence of any other genetic loss of function. During the course of this study, a role for M4 in vivo was suggested by its ability to restore some features of gHV68 infection after recombinant repair of a portion of the 9.5-kb deletion at the left end of the viral genome (Townsley et al., 2004) .
Here, we report an initial characterization of the protein product encoded by the M4 ORF, and assess the requirement for the M4 protein during lytic and latent gHV68 infection in vivo. The M4 transcript was found to be expressed at early times post-infection and initiates with the second methionine of the ORF defined by Virgin et al. (1997) . The M4 protein was found to be a secreted glycoprotein, modified by the addition of hybrid or complex N-linked glycans. In addition, a mutant virus containing a translation stop codon in the M4 open reading frame was found to be impaired in the establishment of splenic latency at early times post-intranasal or intraperitoneal infection. In contrast, the M4 mutant had no effect on establishment or reactivation from peritoneal exudates cells (PECs), demonstrating tissue or cell type-specific requirements for M4 function.
Results
Transcripts corresponding to the M4 ORF are the only species detected in the M4 region during lytic infection
The M4 transcript has previously been shown to be expressed with immediate-early kinetics during lytic infection in vitro (Ebrahimi et al., 2003; Martinez-Guzman et al., 2003; Townsley et al., 2004) . Northern blot analyses were performed in order to begin to characterize transcriptional activity in the area of the M4 ORF and determine if any other transcripts would be likely affected by mutations introduced within the M4 ORF. Examination of infected cellular RNA with a double stranded DNA probe that spanned most of the M4 ORF revealed a predominant species corresponding to the predicted transcript length of ca. 1.2 kb and a minor species ca. 1.9 kb (Figs. 1A and B) . This transcript was detected as early as 4 h post-infection and remained detectable throughout the time course of the experiment. To confirm that this transcript was specific for M4, single stranded probes complimentary to the M4 transcript, or transcripts emanating from the alternate strand, were designed to two distinct locations-immediately downstream of the predicted ORF start and downstream of the second ATG codon (Fig. 1A) . Only the probe complimentary to the M4 transcript at the most downstream position (8447 -95as) was capable of hybridizing to total infected cellular RNA (Fig. 1C, third panel) , and the banding pattern matched that observed with the large double-stranded probe shown in Fig.  1B . The single-stranded probe complementary to the M4 coding strand at the upstream position did not hybridize to any detectable M4 transcript species, nor did either single stranded probe that was designed to the alternative strand (Fig. 1C ). These data demonstrate that the M4 coding region initiates at the second methionine in the open reading frame, in agreement with the findings of Townsley et al. (2004) .
The M4 ORF encodes a secreted glycoprotein
To examine the product of the M4 ORF, the M4 coding sequence was cloned into an expression vector under the control of the cytomegalovirus immediate-early gene promoter with an in-frame FLAG epitope tag at the carboxy-terminus of the M4 ORF (see Materials and methods). This expression vector was transfected into COS-1 cells and the expression of M4 protein assayed by Western blot using a FLAG-specific antibody. Previously reported sequence analysis has suggested that the M4 gene product contains a signal cleavage site near the amino-terminus (Alexander et al., 2002) . As shown in Fig.  2A , two M4 species were readily detected in the supernatant (tissue culture medium) of transfected cells, while no FLAGtagged M4 species were detectable in cell lysates. In addition, a FLAG-tagged M3 protein which served as a positive control (van Berkel et al., 1999) was also observed in the supernatant but not in cell lysates. The FLAG-tagged viral cyclin was readily detected in the whole cell lysate, but not in the culture supernatant, confirming that overexpressed viral protein was readily detectable in the whole cell lysate and that the presence Fig. 2 . M4 is secreted from mammalian cells and modified by the addition of complex N-linked oligosaccharides. M4, M3, and the viral cyclin (v-cyclin, ORF 72) were cloned into a FLAG epitope expression vector and transiently transfected into cos-1 cells. (A) Whole cell lysates and cell supernatants were immunoprecipitated with a-FLAG antibody and detected by Western blot with a-FLAG. M4-FLAG protein was only found in the supernatants of transfected cells, as was the M3-FLAG protein.
The v-cyclin-FLAG protein was only found in transfected cell lysates. (B) Differential susceptibility to modification by endoglycosidases reveals the presence of complex N-linked oligosaccharide residues. M4-FLAG immunoprecipitated from transfected cell supernatants was digested with EndoH or PNGase. M4-FLAG was resistant to digestion with EndoH, but susceptible to digestion with PNGase, suggesting that the glycans present on the secreted M4 protein are of the hybrid or complex variety. The secreted form of M3 has previously been characterized as a 44-kDa protein. , corresponding to each of the two sets of sense and anti-sense single stranded probes used in part C. (B) NIH 3T12 fibroblasts were infected at a multiplicity of infection (MOI) of 5 and total RNA was harvested at the indicated time points. Northern blot analysis was performed with a double stranded DNA probe corresponding to genomic coordinates 8672 to 9422 base pairs. A predominant band was detected of approximately 1.2 kb in length. (C) Single-stranded DNA probes corresponding to 50 bp stretches upstream and downstream of the second possible translation initiation codon were used to analyze total RNA from NIH 3T12 fibroblasts infected for 8 h. Probes were matched for identical G + C content, and both sense (s) and antisense (a-s) orientations were used (+, infected cells; À, mock infection). The banding pattern produced by the probe complimentary to the M4 transcript downstream of the second ATG codon (arrows) was identical to that produced by the double stranded probe. of detectable protein in the supernatant was not the result of incomplete removal of cellular debris ( Fig. 2A) .
Both M4 species observed in the supernatant migrate at a higher molecular weight than the 45 kilodaltons (kDa) predicted by analysis of the primary sequence, while M3 and the viral cyclin migrate at their predicted size (45 and 29 kDa, respectively, Fig. 2A ). Inspection of the predicted M4 protein revealed the presence of seven consensus N-linked glycosylation sites in the carboxy-terminal half of the protein. To determine if the discrepancy between the observed and predicted molecular weight of the secreted protein is the result of glycosylation, FLAG-tagged protein was immunoprecipitated from transfected cell supernatants and digested with two separate endoglycosidases, Endoglycosidase H (Endo H) and Peptide N-Glycosidase F (PNGase). Endo H is a glycosidase which cleaves only asparagine-linked (N-linked) high mannose and some hybrid oligosaccharide structures. Glycans containing other forms of oligosaccharides are resistant to Endo H digestion, while PNGase cleaves high mannose, hybrid, and complex oligosaccharides from N-linked glycoproteins. The M3 protein was used as a control in these reactions, and as predicted was found to migrate at the same size in denaturing gels regardless of endoglycosidase treatment (Fig. 2B ). The secreted M4 species were resistant to EndoH treatment, but treatment with PNGase resulted in a substantial decrease in molecular weight (Fig. 2B ). The deglycosylated protein appeared as a single band of 45 kDa, as originally predicted, suggesting that the two higher molecular weight species represent differentially glycosylated products. Notably, deglycosylation also enhanced detection of M4 by the anti-FLAG antibody, suggesting that glycosylation partially masked antibody recognition of the C-terminal FLAG epitope. These results confirm that the secreted M4 protein is modified with N-linked oligosaccharides of the hybrid or complex variety.
Construction of a cHV68 mutant with a disruption of the M4 open reading frame
In order to study the role of the M4 ORF in the genetic context of gHV68 infection, we generated a mutant virus containing a disruption of the M4 ORF (M4.STOP) by allelic exchange in E. coli. This method has previously been used to generate gHV68 mutants and is described in detail elsewhere (Moorman et al., 2003) . In the M4.STOP virus, the codon immediately following the initiating methionine was mutated to encode a translational termination codon. In addition to the introduction of a translation stop codon, an extra nucleotide was inserted following the stop codon to shift the reading frame of the remaining M4 coding sequence in the event of readthrough of the stop codon (see Materials and methods). The introduction of these mutations into the viral genome also resulted in the generation of a novel AclI site, which was used to confirm the genotype of the M4.STOP mutant by Southern blot (Fig. 3 ). To confirm that any observed phenotypes are the result of the mutation in M4, and not second site mutations introduced by recombination, a marker rescue virus was constructed from the M4.STOP mutant that restored the wild type sequence. Removal of the AclI site was diagnostic of rescue of the M4 mutation and was confirmed by Southern blot (Fig. 3) .
Following confirmation of the correct genotypes, M4.STOP and M4.MR BACs were transfected into Vero-Cre cells, which constitutively express Cre-recombinase, to generate viral stocks. Expression of Cre-recombinase results in removal of the BAC vector sequences from the viral genome. While required for replication of the gHV68 BAC in E. coli, inclusion of BAC vector sequence results in a virus with an attenuated phenotype in vivo (Adler et al., 2001) . Previously, it has been shown that passage of wild type gHV68 BAC through Vero-Cre cells results in viral stocks which lack BAC vector sequence and behave as wild type virus in vitro and in vivo (Moorman et al., 2003) .
M4 is dispensable for lytic viral replication in vitro, but has a modest impact on acute replication in vivo
The ability to generate viral stocks following transfection of M4.STOP BAC DNA into the Vero-Cre cell line indicated that M4 is not essential for in vitro gHV68 lytic replication. To quantitatively measure the growth kinetics of each virus in vitro, M4.STOP, M4.MR, and wild type BAC-derived virus were compared side by side over multiple rounds of viral replication. NIH 3T12 fibroblasts were infected at a multiplicity of infection (MOI) of 0.05 plaque forming units (pfu) per cell with either M4.STOP, M4.MR or wild type virus, and titers were determined over a 96-h time course. As shown in Fig. 4A , M4.STOP, M4.MR, and wild type virus replicated to equivalent titers with similar kinetics over the course of the assay. Thus, M4 is not required for efficient lytic replication in vitro, as expected based on the previously characterized in vitro growth kinetics of gHV68 D9473 and MHV-76 (Clambey et al., 2002; Macrae et al., 2001) .
Although dispensable in vitro, M4 could play a role during acute replication in vivo. To assess this possibility mice were infected with 1 Â10 3 pfu intranasally, and the amount of preformed virus present in the lung was determined on days 4 and 9 post-infection. Mice infected with M4.STOP, M4.MR, or wild type virus contained slightly different levels of virus in lungs at both time points. At day 4 post-infection, M4.STOP virus produced variable titers that did not differ significantly from those produced by M4.MR, and wild type virus, while at day 9 post-infection, lungs from M4.STOP infected animals were found to contain approximately 5-fold less virus than lungs from control infected animals ( Fig. 4B) .
Therefore, the absence of M4 appears to slightly alter the dynamics of acute virus replication in the lung post-intranasal inoculation.
M4 is required for the efficient establishment of latency at early times post-infection after intranasal inoculation
To determine whether M4 plays a role during latent infection, mice were infected intranasally with 1 Â10 3 pfu of M4.STOP, M4.MR, or wild type virus. Significantly less splenomegaly was observed at 16 days post-infection in animals infected with virus containing the M4.STOP allele as compared to wild type (179.7 T 15.8 mg/spleen versus 303.8 T 15.7 mg/spleen, respectively, mean T SEM). The frequency of cells reactivating virus was determined at days 16 or 42 postinfection by harvesting splenocytes and performing a limiting dilution assay as previously described (Weck et al., 1996) . Infected cells were co-incubated with an indicator monolayer and subsequently scored for the cytopathic effect (CPE) that results from reactivating virus. The frequency of splenocytes harboring viral genome was also determined using a limiting dilution PCR assay capable of detecting a single copy of the viral genome in a background of 1 Â10 4 uninfected cells (Weck et al., 1996) . As shown in Fig. 5A , at early times postinfection, splenocytes from mice infected with M4.STOP were found to exhibit an approximately 10-fold decrease in the frequency of cells reactivating virus as compared to M4.MR or wild type virus infected mice. This observed decrease in reactivation closely correlated with the presence of 10-fold fewer viral genome-positive cells in the spleens of M4.STOP infected mice compared to wild type or M4.MR infected mice ( Fig. 5B ), indicating the decreased frequency of reactivation fully reflects a defect in the establishment of splenic latency at this time point.
At late times post-infection (e.g., 42 days), it was not possible to accurately determine the frequency of cells reactivating virus using the limiting dilution assay, as the frequency of reactivating cells was too low (Fig. 5C ). However, by day 42 post-infection the frequency of viral genomepositive cells in the spleen was nearly identical in mice infected with either M4.STOP, M4.MR, or wild type virus ( Fig. 5D ). Notably, at this time point the frequency of M4.STOP genomepositive cells had not substantially changed in the intervening 4 weeks since the day 16 analysis, while the frequency of M4.MR and wild type genome-positive cells decreased approximately 10-fold over this time interval (compare Figs. 5B and 5D). These results indicate that, while important for the efficient establishment of latency at early times post-infection In addition, a single base pair was inserted following the stop mutation to shift the frame of the M4 ORF in the event of read through of the stop codon. The sum of these two mutations introduces a unique AclI site into the M4 locus. The mutations in the M4 locus were rescued to wild type sequence to generate the M4.MR virus to confirm that the phenotypes observed were specific to the M4 mutation, and not the result of spurious mutations introduced during the mutagenesis process. The black bar denotes the location of the probe used for the Southern blot shown in panel B. (B) Southern blot showing the genomic structure of the M4 region in wild type, M4.MR, and M4.STOP viruses. Wild type, M4.MR, and M4.STOP BAC DNA was digested with HindIII (H), AclI (A), or SacII (S) and Southern blot performed using the probe described above. With all three viruses, digestion with HindIII or SacI results in a fragments of 4838 and 9570 base pairs, respectively, confirming that the gross structure of the region is intact in all three BACs. The mutation in M4.STOP results in the introduction of a novel AclI site. Thus, the AclI site in the M4.STOP genome results in the generation of two fragments that hybridize to the probe, of 6442 and 3394 base pairs in size, while a 9816 base pair AclI fragment is generated with wild type and M4.MR viruses. The observed higher molecular weight bands present in many of the lanes reflect partial digestion of the BAC DNA into fragments too large to discern at this resolution.
(day 16), M4 does not appear to be required for the maintenance of latency in vivo.
Loss of M4 alters splenic latency following intraperitoneal inoculation, but does not affect establishment of latency in peritoneal cells
The transient defect in the establishment of splenic latency observed with the M4 mutant led us to question whether a delay in trafficking of virus to the spleen could explain the observed phenotype. By altering the route of infection, we hoped to observe a differential requirement for M4 function. Intraperitoneal infection alters the trafficking requirements for the establishment of splenic latency, as B cells are required for splenic latency after intranasal but not intraperitoneal infection (Usherwood et al., 1996b; Weck et al., 1996) . The intraperitoneal route also provides for robust latent infection outside of the spleen, as PECs are directly infected and subsequently harbor latent virus presumably without any requirement for trafficking of infected cells. We have previously observed phenotypes that are dependent upon both the inoculation route and anatomic site of infection in the establishment of gHV68 latency (Herskowitz et al., 2005; Jacoby et al., 2002) . In order to explore this possibility for M4, mice were infected with 1 Â10 3 pfu of either M4.STOP, M4.MR, or wild type virus via intraperitoneal inoculation. Both splenocytes and PECs were analyzed at 16 days post-infection as described above. Splenocytes from mice infected with M4.STOP demonstrated a ca. 10-fold decrease in the frequency of cells reactivating virus (Fig. 6A ), similar to the defect observed post-intranasal inoculation. Notably, the frequency of M4.STOP-infected splenocytes harboring viral DNA was only decreased by ca. 3-fold ( Fig. 6B ), suggesting that there may be a slight reactivation defect following intraperitoneal inoculation that was not observed following intranasal inoculation (Table 1) . However, there was sufficient variability in the reactivation analyses to make this subtle difference difficult to discern (see Fig. 6A ).
Direct infection of the peritoneal cavity leads to the establishment of latency within PECs, primarily in macrophages (Weck et al., 1999b) . In contrast to the observed defect in the establishment of latency with the M4.STOP virus in the spleen, examination of the PECs revealed no affect of loss of M4 as both the frequency of latently infected cells reactivating virus and containing viral DNA were equivalent between animals infected with M4.STOP and control viruses (Figs. 6C and D). Thus, either the difference in predominant cell type harboring latent virus within the peritoneal cavity, and/or the absence of virus trafficking obviates the requirement for M4 function.
Discussion
Here, we report a preliminary characterization of the M4 protein and the first analysis of the role of the M4 gene during gHV68 pathogenesis. In confirmation of previous work (Ebrahimi et al., 2003; Martinez-Guzman et al., 2003; Townsley et al., 2004) , the M4 transcript was found to be expressed at early times post-infection. Based on singlestranded Northern blot analyses, we confirmed that the M4 protein initiates from the second methionine in the predicted ORF (Townsley et al., 2004; Virgin et al., 1997) . This protein product was secreted from cells transfected with an M4 expression construct, and the secreted product was modified by the addition of N-linked glycans. M4 is the second viral gene product encoded by gHV68 to be identified as a secreted molecule, along with the M3 chemokine binding protein (van Berkel et al., 2000; van Berkel et al., 1999) . Disruption of the M4 ORF by the introduction of a translational termination codon immediately following the initiating methionine did not significantly affect lytic replication in vitro. It did, however, modestly alter the dynamics of Fig. 4 . In vitro and in vivo replication of M4.STOP, M4.MR, and wild type virus. (A) NIH 3T12 cells were infected at an MOI of 0.05, and wells were harvested at the indicated time points. Virus titers were quantitated by plaque assay on 3T12 monolayers (see Materials and methods) Wild type, M4.MR, and M4.STOP viruses were found to replicate to equivalent titers with similar kinetics. The data represent the sum of two experiments, with the error bars denoting the standard error of the mean. (B) Six-to 8-week-old C57Bl6/J mice were infected with 1 Â10 3 pfu of each virus intranasally. Lungs were harvested at days 4 or 9 post-infection, homogenized, and the amount of virus quantitated by plaque assay on 3T12 monolayers (see Materials and methods). Three-fold more virus was found in the lungs of mice infected with M4.STOP as compared to mice infected with either wild type or M4.MR virus at day 4 post-infection, but this difference was not statistically significant (P value ! 0.0566). At day 9 post-infection, the lungs of mice infected with M4.STOP virus contained 5-fold less virus than lungs from mice infected with M4.MR or wild type virus (*P value 0.0397, unpaired, one-tailed P value). The data were compiled from two separate experiments, with four to five mice per group per experiment. The black bar denotes the mean titer of the group. acute lung infection in vivo. The extent to which a mild replication defect impacts the ability of the virus to establish latency is an open question. However, we have previously failed to observe a significant impact of virus dose on the establishment of latency even though it substantially impacts lytic virus replication in the lungs (Tibbetts et al., 2003) . In addition, recent data indicate that establishment of latency in the lung occurs as early as 2 to 3 days post-infection (Flano et al., 2005) , at a time when we did not observe any defect in acute replication of the M4.STOP virus in the lungs of infected mice. Thus, it seems unlikely that the modest decrease in virus replication in the lung observed at day 9 post-infection with the M4.STOP virus has a significant impact on the establishment of latency.
Following intranasal inoculation, loss of M4 function decreased the frequency of viral genome-positive cells in the spleen by 90%, although this defect was no longer evident by 6 weeks post-infection. It is possible that the early defect in splenic latency is the result of delayed trafficking of latently infected cells from the lung to the spleen based on several factors: (i) the defect was temporary, (ii) M4 impacted early events in the lung, (iii) M4 is expected to act via an Table 1 . The data were compiled from three independent experiments, with five mice per group per experiment. Intranasal (i.n.) and intraperitoneal (i.p.) inoculation. b Frequency analysis was based on the application of the Poisson distribution to the limiting dilution data in Figs. 5 and 6. The cell count at which 63.2% of wells are estimated to contain positive events represents the frequency at which those events occurred. c Reactivation efficiency was determined by calculating the ratio of the frequency of reactivating cells to the frequency of genome-positive cells.
extracellular mechanism in an autocrine or paracrine fashion, and (iv) M4 transcription is immediate-early and predominantly within sites of acute infection (Simas et al., 1999; . Other possible explanations include a role for M4 in modulating immune clearance of latently infected cells, or that it is involved in proliferation of latently infected cells. With respect to the latter, we have recently shown that B cell proliferation is a critical aspect of establishment of gHV68 latency in the spleen (Moser et al., 2005) . To examine the possibility of a trafficking phenotype, an alternative route of infection was chosen. Intraperitoneal inoculation alters the trafficking requirements for the establishment of splenic latency as compared to intranasal infection; B cells are required for trafficking virus from the lung to the spleen (Usherwood et al., 1996b) , but they are not required to establish splenic latency following intraperitoneal infection (Weck et al., 1996) . In addition to altering trafficking requirements for splenic and PEC latency, intraperitoneal inoculation provides a means of comparing cell type-specific requirements of latency. The predominant cell type harboring latent infection differs between the spleen and peritoneal cavity-B cells represent the majority of latently infected cells in the spleen , while macrophages comprise the bulk of peritoneal latency (Weck et al., 1999b) . Following intraperitoneal inoculation, the M4.STOP virus was able to establish and reactivate from PEC latency equivalent to wild type and M4.MR rescue viruses, but splenic latency was diminished. This difference may be attributed to either the predominant cell types infected in the PECs versus spleen, or the relative contribution of direct infection versus systemic spread upon establishment at each anatomical site, respectively. The defect that did occur in intraperitoneal splenic latency was not as substantial as after intranasal inoculation, which may reflect some commonalities, but also differences, in the requirements for trafficking to the spleen that are inherent to each route of infection.
A role for M4 in gHV68 reactivation from latency is considered unlikely. M4.STOP virus produced no detectable change in PEC reactivation, nor was the reactivation efficiency decreased following intranasal inoculation (Table 1 ). It is known that the overwhelming majority of reactivating virus from explanted splenocytes arises from latently infected B cells (Marques et al., 2003; Willer and Speck, 2003) . The fact that M4.STOP displays no reactivation defect after intranasal inoculation, but exhibits a slight reactions defect following intraperitoneal infection, suggests the virus is less reliant on M4 function for seeding the spleen which B cells are not required. While the use of intraperitoneal infection did not conclusively demonstrate a role for M4 in the trafficking of latently infected virus to the spleen, it did distinguish a requirement for M4 function in different cell populations. The ability of the M4 gene product to impact the initial establishment of splenic latency also provides further evidence that the significant changes in latency associated with the pathogenesis of the gHV68 D9473 and MHV76 viruses are the result of combinatorial effects. The extent to which any of the Table 1 . The data were compiled from two or three independent experiments, with five mice per group per experiment. genes located at the left-end of the viral genome act in concert with one another is currently under investigation. Some important differences exist between the approach taken here to assess M4 function and those previously reported (Townsley et al., 2004) . The previous analysis depended upon a recombinant virus constructed from MHV-76 (Macrae et al., 2001) , which lacks the same 9.5 kb region which is deleted in the D9473 gHV68 mutant. Townsley et al. (2004) reported that insertion of a 3.5-kb of genomic sequence, which includes the M4 ORF as well as 995 bp of ''noncoding'' upstream sequence (containing putative M4 cis-regulatory elements) and 1,129 bp of sequence downstream of the M4 translation stop codon, into the MHV-76 genome produced a recombinant virus (MHV76inM4) that partially restored features of gHV68 latency. This result suggested that the product of the M4 ORF plays a role during latency. However, several problems exist with this approach. First, the impact of genetic sequences located outside the M4 ORF was not addressed in this study. Upstream sequences introduced into the MHV-76 genome may have affected latency, as the authors' transcriptional analysis of M4 expression in this recombinant virus revealed appreciable differences compared to gHV68. The degree of cyclohexamide induced repression of M4 transcription varied between gHV68 and MHV76inM4, and M4 transcription in vivo was detected at much later time points from the MHV76inM4 virus. Second, the study of MHV76inM4 lacked a targeted disruption of the M4 ORF, and thus differences observed between MHV76 and MHV76inM4 have not been conclusively mapped to M4 gene expression. Finally, characterization of the M4 ORF in the absence of several genes important for gHV68 latency does not allow an evaluation of the contribution of the M4 gene product to viral latency in its natural genetic context. Our analysis demonstrates M4 is required to establish normal latent load specifically in a splenocyte population, consistent with a B cell deficit. In light of this finding, the MHV-76 in M4 study is severely limited by the fact that the virus lacks a number of viral genes that impact pathogenesis, namely M1 and M2 which have been shown to be important modulators of gHV68 latency (Clambey et al., 2000; Jacoby et al., 2002; Macrae et al., 2003) .
The results presented here are consistent with a role for M4 in helping to efficiently traffic latent virus to the spleen, but they do not rule out other explanations. Broadly, it is tempting to speculate that the role of the secreted protein is to modulate the host immune system based on the observation that many non-essential herpesvirus genes act in this capacity. The neighboring M3 gene has been shown to encode the most abundantly secreted viral protein following gHV68 infection (van Berkel et al., 1999) . Several studies have shown that the M3 protein is involved in binding to host chemokines secreted in response to infection (Alcami, 2003; Jensen et al., 2003; Seet and McFadden, 2002; van Berkel et al., 2000) . Surprisingly, the absence of M3 does not have an appreciable impact on gHV68 latency . Perhaps, the M4 protein binds to host chemokines which localize infected cells to the site of lytic infection. In the absence of M4, infected cells which would normally traffic to the spleen remain trapped at the site of infection. Following resolution of the initial inflammatory event and subsequent down regulation of the interacting chemokine, the infected cells would be free to traffic to the spleen, thus explaining the equivalent numbers of viral genome-positive cells found in the spleens of mice infected with M4.STOP, M4.MR, and wild type virus at late times post-infection. Alternatively, M4 could mimic chemokine activity and act as a recruitment factor responsible for eliciting migration of a specific cell population to the lung that is required for dissemination to the spleen. A similar paradigm has been shown to occur in murine cytomegalovirus (MCMV), a member of the h-herpesvirus family. MCMV encodes a CC chemokine homolog, MCK-2, that is responsible for recruiting leukocytes to the footpad site of infection thereby providing a vehicle for efficient dissemination and trafficking to the salivary glands (Noda et al., 2005; Saederup et al., 1999 Saederup et al., , 2001 . Outside of this realm, the secreted M4 protein could modulate host responses by acting as a ligand agonist or antagonist for any of the numerous regulatory receptors of the immune system. The fact that M4 expression is much less abundant than M3 and seems to occur within more limited tissues and cell types in vivo, yet appreciably impacts viral latency where as M3 does not, may be seen to support this latter notion. Studies are currently under way to determine the function of the secreted M4 protein.
Materials and methods
Viruses and tissue culture Viral stocks were generated by transfecting gHV68 BAC clones into Vero-Cre cells. Following the appearance of cytopathic effect, wells were harvested and used to infect Vero-Cre cells to generate high titer viral stocks. NIH 3T12 cells and mouse embryonic fibroblasts (MEFs) were maintained in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal calf serum, 100 U of penicillin per ml, 100 mg of streptomycin per ml, and 2 mM l-glutamine (complete DMEM). Cells were maintained in a 5% CO 2 tissue culture incubator at 37 -C. MEFs were obtained from either BALB/c or C57BL/6 mouse embryos as described previously (Weck et al., 1996) . Vero-Cre cells were a gift from Dr. David Leib. Cells were passaged in DMEM supplemented with 10% fetal calf serum and 300 Ag/ml Hygromycin B.
RNA preparation and Northern blotting
NIH 3T12 fibroblasts were infected with WT virus at a multiplicity of infection of 5. At 2, 4, 8, 16 , and 24 h postinfection, total RNA was harvested by single-step isolation as previously described (van Berkel et al., 1999) . Briefly, cells were harvested into 7 ml GITC-phenol (10:1:10 mixture of the following: [i] 4M guanidine isothiocyanate, 0.1 M mercaptoethanol, 0.5% sarcosyl, [ii] 2M sodium acetate pH 4.0, [iii] H 2 0-saturated phenol). Samples were chloroform extracted, and the upper aqueous phase was isopropanol precipitated. RNA was stored in 75% ethanol at À80 -C until needed.
Northern blot analysis was performed as previously described (van Berkel et al., 1999) . Briefly, 5 Ag of total RNA was loaded into each lane of a 1.5% agarose, denaturing gel. As a basis for size comparison, 2.5 Ag of an RNA ladder (New England Biolabs, Beverly, MA) was run alongside. RNA was transferred to a nylon membrane overnight, prehybridized for at least 1 h, and hybridized with radiolabeled probe for up to 18 h at 42 -C. Washes were performed at 55 -C for 30 min each, twice with 2 Â SSC/0.1% SDS, and once with 0.2 Â SSC/ 0.1% SDS. Blots were visualized either by exposure to X-Omat Blue film (Kodak, Rochester, NY) and development on a Konica SRX-101 Film Processor, or by exposure to a Storage Phosphor Screen and development on Typhoon 9410 Variable Mode Imager (Amersham Biosciences).
Double-stranded DNA probes were generated using the Megaprime DNA Labelling System (Amersham Biosciences) to generate [ 32 P]-labeled nucleic acid from the 747 bp SpeI/ PvuII restriction endonuclease fragment contained within the M4 ORF. Single-stranded DNA probes, matched for identical G + C content, were designed to correspond to two 50-bp stretches upstream and downstream of the second ATG codon in the M4 ORF (genomic coordinates 8447 -8495 and 8621 -8669, respectively, Genbank Accession #NC 001826). Antisense (a-s, complimentary to mRNA) and sense (s) oligonucleotides were generated for each region. Oligonucleotide sequences were the following: 8447 -95 a-s, 5V-CCA AAA ATT CTA TTG GGC AAT CAG GGA TGA TCT AAT TAT CCA TGG AGG C-3V; 8447-95 s, 5V-GCC TCC ATG GAT AAT TAG ATC ATC CCT GAT TGC CCA ATA GAA TTT TTG G-3V; 8621 -69 a-s, 5V-AGA AGA TGA TGA TAT TCC TGT AAA AAT CCA TCG GCT GAC CTT CGT GAA G-3V; 8621 -69 s, 5V-CTT CAC GAA GGT CAG CCG ATG GAT TTT TAC AGG AAT ATC ATC ATC TTC T-3V. 10 pmol of each oligonucleotide was end-labeled with [ 32 P] in a polynucleotide kinase (New England Biolabs) reaction, per manufacturer's instructions, and probes were purified over G-25 Sephadex columns (Roche, Indianapolis, IN). Single stranded probes were determined to have comparable levels of [ 32 P] incorporation.
Western blot, immunoprecipitation, and glycosidase assay M4 coding sequence (genomic coordinates 8538 -9785) was PCR amplified from gHV68 BAC DNA, incorporating a SacI restriction site and Kozac sequence immediately upstream of the translational start site and a XhoI restriction site immediately downstream of the last codon. Primer sequences were the following: 5V-TCG AAC GAG CTC GCC GCC ATG GTG GGC ACC CAG CCT AG-3V and 5V-GGT TGC CTC GAG TTC TAG AAA GTC ATA AAT CTC-3V. PCR products were cloned into pCR-Blunt (Invitrogen, Carlsbad, CA), sequenced to confirm fidelity, and subcloned into the SacI and XhoI sites of the pCMV-Tag4B epitope-tagging mammalian expression vector (Stratagene, Cedar Creek, TX). The M3 expression vector was generated in an identical manner, using primer sequences that correspond to genomic coordinates 6060 -7277. The v-cyclin expression vector was generated by cloning sequence corresponding to genomic coordinates 102,423 -103,181 into pCMV-Tag2B (Stratagene).
Expression vectors were transfected into Cos-1 cells using TransIT-LT1 Reagent (Mirus, Madison, WI), per manufacturer's instructions. After 48 h, transfected cell supernatants were removed and immunoprecipitated overnight using 30 Al ANTI-FLAG M2-agarose affinity gel (Sigma, St. Louis, MO). Cells lysates were prepared by the addition of E1A lysis buffer (50 mM HEPES pH 7.2, 250 mM NaCl, 2 mM EDTA, and 0.1% NP-40) followed by a twenty min incubation. Western Blots were performed according to standard protocol. Briefly, whole cell lysates and immunoprecipitates were denatured and separated by SDS-PAGE and transferred to nitrocellulose membrane. Nitrocellulose was blocked for 1 h at room temperature, immunoblotted overnight at 4 -C with ANTI-FLAG M2-peroxidase conjugated antibody (Sigma), and antibody was detected using ECL Western blot analysis System (Amersham Biosciences, Buckinghamshire, UK). Endoglycosidase susceptibility was determined by incubating immunoprecipitated protein with either Endoglycosidase H (Endo H f ) or N-glycosidase F (PNGase F) (New England Biolabs) per manufacturer's instructions.
Construction of M4.STOP and M4.MR viruses
To assess the requirement for the M4 protein during gHV68 infection, we constructed a gHV68 mutant in which the M4 open reading frame is disrupted by a translational stop codon immediately following the initiating methionine (M4.STOP). The M4.STOP virus was constructed using allelic exchange in RecA-positive E. coli (GS500), as described previously (Moorman et al., 2003) . Briefly, overlap PCR was used to mutate the codon immediately following the identified initiating methionine to a translation termination codon, and an extra base was inserted downstream of the stop codon to frameshift the rest of the reading frame in the event of translational readthrough of the stop mutation. PCR was performed with Vent polymerase, which has proofreading activity. The wild type sequence was 5V GCG ATG GGA CCG TTA GGA AGA CC 3V and the sequence of the mutant is 5VGCG ATG TGA ACG TTA tGG AAG ACC 3V. The translational stop is shown in italics, and the inserted base is indicated by lowercase type. This mutation also results in the formation of a novel AclI restriction site (underlined). The coordinates for the wild type sequence listed correspond to genomic sequences 8535 to 8557. The PCR product was cloned into the suicide vector pGS284, and allelic exchange was performed with this vector and wild type BAC to generate the M4.STOP BAC. To confirm that the phenotypes observed were the result of the M4 mutation and not a second site mutation, the mutation in M4.STOP was rescued to wild type sequence (M4.MR) using the same methodology. Genomic sequences 7828 to 9178 were amplified and cloned into pGS284, and allelic exchange was performed with this vector and the M4.STOP BAC. Rescue of the mutation was checked by PCR, then the structure of all recombinant BACs were confirmed by restriction digest with AclI and detection by Southern blot (Fig. 3) . The same PCR product (7828 to 9178) was labeled with aP 32 -dCTP by random priming and used as the probe for the diagnostic Southern blot. As PCR was used to generate the recombination targeting vectors, the sequences of the M4.STOP and M4.MR targeting vectors were confirmed by sequencing prior to recombination.
Mice, infections, and organ harvests C57BL/6 mice were purchased from the Jackson Laboratories and used between 8 -12 weeks of age. Mice were placed under isofluorane anesthesia prior to infection, as well as before sacrifice by cervical dislocation. Intranasal inoculations were performed in a volume of 20 Al complete DMEM, while intraperitoneal inoculations consisted of 200 Al. Upon sacrifice, lungs were placed in 0.5 ml of complete DMEM and frozen at À80 -C. Sentinel mice were assayed every 3 months and were negative for adventitious mouse pathogens by serology.
Plaque assays
Plaque assays were performed using NIH 3T12 monolayers under noble agar overlay as described previously (Weck et al., 1999a) , with the following alterations. NIH 3T12 cells were plated in 6-well plates at 2 Â 10 5 cells per well the day prior to infection. Organs to be titered were thawed, homogenized by mechanical disruption in a Mini-Beadbeater 8 (Biospec Products, Bartlesville, OK), and then 10-fold dilutions made in complete DMEM were plated onto NIH 3T12 cell monolayers. Infections were performed in a 200-Al volume and plates were rocked every 15 min for 1 h at 37 -C. Samples were overlaid with 3 ml of a 1:1 mixture of 3% noble agar and 2Â MEM supplemented with 20% FCS and 2Â concentration of antibiotic and l-glutamine. An additional 2 ml of noble agar, 2Â MEM mixture was added on day 3 post-plating. Monolayers were stained between day 6 and 8 by the addition of 2 ml of neutral red overlay (0.01% neutral red in serum-free DMEM). After 18-24 h, plaques were counted. The limit of detection for this assay is 50 PFU per organ.
Limiting dilution ex vivo reactivation assay
Detection of gHV68 reactivation from latency was performed as previously described (Weck et al., 1999a) . Briefly, splenocytes and PECs were harvested on days 16 or 42 postinfection, and single cell suspensions were generated. Spleen samples underwent erythrocyte lysis with ammonium chloride, and all cells were resuspended in complete DMEM and plated in a series of 2-fold dilutions, starting at 1 Â10 5 cells per well, onto MEF monolayers in 96-well tissue culture plates. After 21 days, wells were scored microscopically for the presence of CPE. In some cases, samples were replated on fresh MEF monolayers to confirm the presence of infectious virus. 24 wells were plated per dilution with a total of 12 dilutions per sample per experiment. To detect preformed infectious virus, parallel samples were resuspended in 1/3Â DMEM in the presence of 0.5 mm silica beads and subjected to four rounds of one min mechanical disruption in a Mini-Beadbeater-8 as previously described. This disruption procedure kills >99% of cells, with at most a 2-fold effect on the titer of preformed infectious virus (Weck et al., 1999a) . Disrupted cells were plated in a similar series of 2-fold dilutions.
Limiting dilution nested PCR detection of cHV68 genome-positive cells
We determined the frequency of cells containing gHV68 genome using a previously described nested PCR assay (LD-PCR) with ca. single copy sensitivity to detect gene 50 of gHV68 (Weck et al., 1999a) . Briefly, splenocytes and PECs were harvested from latently infected mice and frozen in complete DMEM with 10% DMSO at À80 -C, thawed, counted, resuspended in an isotonic solution, and diluted in a background of 1 Â10 4 uninfected NIH 3T12 cells. After overnight lysis of cells with proteinase K, a first round PCR was performed on each sample. Subsequently, second round reaction mix was added directly to the first round and cycles performed. Products were analyzed by ethidium bromide staining of a 2% agarose gel. Twelve PCR reactions were performed for each cell dilution with 6 dilutions per sample per experiment. With each set of samples, 6 water controls and 18 controls for PCR sensitivity were included. To quantitate PCR sensitivity, 10, 1 or 0.1 copies of a gene 50 containing plasmid (pBamHI N) were diluted into a background of 1 Â10 4 uninfected cells. This PCR protocol can detect a single copy of a gene 50 containing plasmid (pBamHI N) diluted in a background of carrier DNA and 1 Â10 4 uninfected cells witḧ 50% frequency.
